Found: 21
Select item for more details and to access through your institution.
Correction: Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting?
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Measuring cfDNA integrity as a biomarker for predicting neoadjuvant chemotherapy response in breast cancer patients: a pilot study.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 206, n. 2, p. 329, doi. 10.1007/s10549-024-07366-y
- By:
- Publication type:
- Article
Measuring serum oestrogen levels in breast cancer survivors using vaginal oestrogens: a systematic review.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 206, n. 2, p. 215, doi. 10.1007/s10549-024-07364-0
- By:
- Publication type:
- Article
Correction: Five-year survival prognosis of young, middle-aged, and elderly adult female invasive breast cancer patients by clinical and lifestyle characteristics.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Racialized economic segregation and inequities in treatment initiation and survival among patients with metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 206, n. 2, p. 411, doi. 10.1007/s10549-024-07319-5
- By:
- Publication type:
- Article
Unveiling the potential of breast MRI: a game changer for BI-RADS 4A microcalcifications.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 206, n. 2, p. 425, doi. 10.1007/s10549-024-07320-y
- By:
- Publication type:
- Article
Prognostic significance and value of further classification of lymphovascular invasion in invasive breast cancer: a retrospective observational study.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 206, n. 2, p. 397, doi. 10.1007/s10549-024-07318-6
- By:
- Publication type:
- Article
Impact of HER2 status on clinicopathological characteristics and pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 206, n. 2, p. 387, doi. 10.1007/s10549-024-07317-7
- By:
- Publication type:
- Article
Circulating tumour DNA dynamics during alternating chemotherapy and hormonal therapy in metastatic breast cancer: the ALERT study.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 206, n. 2, p. 377, doi. 10.1007/s10549-024-07316-8
- By:
- Publication type:
- Article
Body composition measures as a determinant of Alpelisib related toxicity.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 206, n. 2, p. 369, doi. 10.1007/s10549-024-07315-9
- By:
- Publication type:
- Article
Ethnic disparities in breast cancer patterns in Brazil: examining findings from population-based registries.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 206, n. 2, p. 359, doi. 10.1007/s10549-024-07314-w
- By:
- Publication type:
- Article
Superior suppression of serum estrogens during neoadjuvant breast cancer treatment with letrozole compared to exemestane.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 206, n. 2, p. 347, doi. 10.1007/s10549-024-07313-x
- By:
- Publication type:
- Article
Tolerability and effectiveness of palbociclib in older women with metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 206, n. 2, p. 337, doi. 10.1007/s10549-024-07312-y
- By:
- Publication type:
- Article
Disentangling the relationships of body mass index and circulating sex hormone concentrations in mammographic density using Mendelian randomization.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 206, n. 2, p. 295, doi. 10.1007/s10549-024-07306-w
- By:
- Publication type:
- Article
Breast cancer (BC) and severe COVID-19 (C-19) outcomes: a matched analysis.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 206, n. 2, p. 307, doi. 10.1007/s10549-024-07301-1
- By:
- Publication type:
- Article
Circulating microRNAs and therapy-associated cardiac events in HER2-positive breast cancer patients: an exploratory analysis from NeoALTTO.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 206, n. 2, p. 285, doi. 10.1007/s10549-024-07299-6
- By:
- Publication type:
- Article
Evaluation of markers of immunity in different metastatic immune microenvironments suggests more suppression within breast to liver metastases in breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 206, n. 2, p. 245, doi. 10.1007/s10549-024-07295-w
- By:
- Publication type:
- Article
First-line therapy with palbociclib in patients with advanced HR<sup>+</sup>/HER2<sup>−</sup> breast cancer: The real-life study PALBOSPAIN.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 206, n. 2, p. 317, doi. 10.1007/s10549-024-07287-w
- By:
- Publication type:
- Article
A whole food, plant-based randomized controlled trial in metastatic breast cancer: feasibility, nutrient, and patient-reported outcomes.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 206, n. 2, p. 273, doi. 10.1007/s10549-024-07284-z
- By:
- Publication type:
- Article
Uptake of screening and risk-reducing recommendations among women with hereditary breast and ovarian cancer syndrome due to pathogenic BRCA1/2 variants evaluated at a large urban comprehensive cancer center.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 206, n. 2, p. 261, doi. 10.1007/s10549-024-07283-0
- By:
- Publication type:
- Article
Neoadjuvant chemotherapy for triple-negative and Her2 +ve breast cancer: striving for the standard of care.
- Published in:
- Breast Cancer Research & Treatment, 2024, v. 206, n. 2, p. 227, doi. 10.1007/s10549-024-07282-1
- By:
- Publication type:
- Article